EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study

James O'Beirne, Richard Skoien, Barbara A Leggett, Gunter F Hartel, Louisa G Gordon iD, Elizabeth E Powell, Patricia C Valery iD

Medical Journal of Australia · 2023

DOI: 10.5694/mja2.52104 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Medical Journal of Australia, 2023. Verfasst von James O'Beirne und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of the Sunshine Coast, Buderim, QLD. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Liver Cirrhosis, Diabetes Mellitus. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sunshine Coast University Hospital and Health Service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the incidence of decompensated cirrhosis and associated risk factors in people hospitalised with non‐alcoholic fatty liver disease (NAFLD) or non‐alcoholic steatohepatitis (NASH) with or without cirrhosis.

Design

Retrospective cohort study; analysis of linked Queensland Hospital Admitted Patient Data Collection, Queensland Registry of Births, Deaths and Marriages, and Queensland Cancer Register data. Setting, participants Queensland residents aged 20 years or older admitted to Queensland hospitals with NAFLD/NASH during 1 July 2009 – 31 December 2018. Main outcome measures Progression to decompensated cirrhosis (ascites, hepatic encephalopathy, or oesophageal variceal bleeding).

Results

We included data for 8006 patients in our analysis (10 082 admissions), including 4632 women (58%) and 2514 people with diabetes mellitus (31%); median follow‐up time was 4.6 years (interquartile range, 2.7–7.2 years). Three hundred and fifty‐one people (4.4%) experienced decompensated cirrhosis during the follow‐up period. Of the 6900 people without cirrhosis, 4.5% (95% confidence interval [CI], 3.6–5.7%) experienced decompensated cirrhosis within ten years (mean, 0.5% per year; 95% CI, 0.4–0.6% per year); risk of progression was greater for people aged 70 years or older ( v 20–39 years: adjusted hazard ratio [aHR], 4.7; 95% CI, 2.0–11.0) and those who had extrahepatic cancers (aHR, 5.0; 95% CI, 3.0–8.2), history of major cardiovascular events (aHR, 1.9; 95% CI, 1.2–3.1), or diabetes mellitus (aHR, 2.8; 95% CI, 2.0–3.9). Of the 1106 people with cirrhosis, 32.4% (95% CI, 27.2–38.3%) experienced decompensated cirrhosis within ten years (mean, 5.5% per year; 95% CI, 4.8–6.3% per year); risk of progression was greater for those with portal hypertension (aHR, 1.8; 95% CI, 1.3–2.7), extrahepatic cancer (aHR, 1.8; 95% CI, 1.1–2.9), or diabetes mellitus (aHR, 1.5; 95% CI, 1.1–2.0). Compared with people who had neither cirrhosis nor diabetes mellitus, the risk of decompensation was greater for people with cirrhosis (aHR, 10.7; 95% CI, 7.6–15.0) or cirrhosis and diabetes mellitus (aHR, 14.4; 95% CI, 10.1–20.6).

Conclusions

Given the greater risk of progression to cirrhosis decompensation in people with diabetes mellitus, a disorder common in people with NAFLD/NASH, identifying advanced fibrosis and providing appropriate treatment for averting disease progression is vital.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseLiver CirrhosisDiabetes MellitusHumansFemaleRetrospective StudiesMaleMiddle AgedDisease ProgressionQueenslandRisk FactorsAgedAdultIncidenceEsophageal and Gastric Varices

Stichwörter der Autor:innen

Encephalitis, viralLiver cirrhosisLiver diseases

Autor:innen und Institutionen

  • University of the Sunshine Coast, Buderim, QLD.
  • Sunshine Coast University Hospital, Kawana Waters, QLD.
  • Royal Brisbane and Woman's Hospital Health Service District, Brisbane, QLD.
  • The University of Queensland, Brisbane, QLD.
  • QIMR Berghofer Medical Research Institute, Brisbane, QLD.
  • Queensland University of Technology, Brisbane, QLD.

ORCID-Profile: Louisa G Gordon, Patricia C Valery

Förderung

  • Sunshine Coast University Hospital and Health Service

Zitieren

APA

O'Beirne, J., Skoien, R., Leggett, B. A., Hartel, G. F., Gordon, L. G., Powell, E. E., & Valery, P. C. (2023). Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study. Medical Journal of Australia. https://doi.org/10.5694/mja2.52104

Vancouver

O'Beirne J, Skoien R, Leggett BA, Hartel GF, Gordon LG, Powell EE, et al. Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study. Medical Journal of Australia. 2023. doi:10.5694/mja2.52104

BibTeX
@article{OBeirne2023,
  author = {O'Beirne, James and Skoien, Richard and Leggett, Barbara A and Hartel, Gunter F and Gordon, Louisa G and Powell, Elizabeth E and Valery, Patricia C},
  title = {Diabetes mellitus and the progression of non‐alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study},
  journal = {Medical Journal of Australia},
  year = {2023},
  doi = {10.5694/mja2.52104}
}
Kostenlos starten →